Page last updated: 2024-08-23

etoposide and Bladder Cancer

etoposide has been researched along with Bladder Cancer in 111 studies

Research

Studies (111)

TimeframeStudies, this research(%)All Research%
pre-199017 (15.32)18.7374
1990's48 (43.24)18.2507
2000's30 (27.03)29.6817
2010's13 (11.71)24.3611
2020's3 (2.70)2.80

Authors

AuthorsStudies
Benites, J; Ibacache, A; Rodriguez, JA; Theoduloz, C; Valderrama, JA1
Ando, T; Hanai, K; Kamitani, R; Kashizaki, F; Mizuno, R; Sekido, Y; Tanaka, A1
Fuchigami, Y; Iguchi, R; Magaribuchi, T; Naito, H; Ota, H; Shibasaki, N; Terai, A; Tsuruta, M; Yamaguchi, T1
Chumbalkar, V; Howe, AS; Kogan, BA; Lian, F; Nazeer, T; Pearce, J; Ribbons, L1
Hashizume, A; Jikuya, R; Kawai, M; Kishida, T; Mizuno, N; Muraoka, K; Tatenuma, T; Umemoto, S; Washimi, K; Yasui, M1
Bocchia, M; Cencini, E; Fabbri, A; Gentili, F; Mazzei, MA; Schiattone, L1
Bryant, CM; Dang, LH; Gilbert, SM; Morris, CG; Stechmiller, BK; Zlotecki, RA1
Arai, H; Honda, M; Kobayashi, Y; Ueda, N; Yoshida, K1
Appaji, L; Padma, M; Ramanathan, S; Suma, MN; Suma, TL1
Clozel, T; Elemento, O; Erdem, Z; Hassler, MR; Krzywinski, M; Robinson, BD; Shariat, SF; Xylinas, E; Zhuang, D1
Heidegger, I; Horninger, W; Pichler, R; Schäfer, G; Tulchiner, G1
Fujii, Y; Fukui, I; Kawakami, S; Komai, Y; Okubo, Y; Yamamoto, S; Yonese, J1
Dinney, CP; Grossman, HB; Kamat, AM; Millikan, RE; Qiao, W; Siefker-Radtke, AO; Thall, PF; Williams, DL1
Kawashima, A; Miyoshi, S; Nin, M; Nishimura, K; Ujike, T1
He, DW; Li, XL; Lin, T; Liu, JH; Liu, X; Wei, GH; Zhang, DY1
Araki, M; Hasegawa, H; Ikura, Y; Itoh, M; Kuzushita, N; Mita, E; Nakazuru, S; Ohta, M; Suemura, S; Toyama, T; Yoshio, T; Yoshioka, C1
Cassier, P; Chapet, O; Chekrine, T; De Bari, B; Kulisa, M; Mornex, F1
Fukui, I; Kitsukawa, S; Komai, Y; Kubo, Y; Okubo, Y; Saito, K; Urakami, S; Yamamoto, S; Yasuda, Y; Yonese, J1
Aiello, E; Colarossi, C; Costanzo, R; Giuffrida, D; Martinetti, D; Memeo, L; Pino, P1
Chen, WJ; Chuang, JH; Huang, HY; Jeng, YM; Ko, SF; Sung, MT1
Fukui, I; Ishii, N; Maezawa, T; Tsukamoto, T; Yonese, J1
Berry, LR; Chan, AK; Paredes, N; Xu, L1
Austin, RC; Baumeister, P; Kaufman, RJ; Lee, AS; Mao, C; Reddy, RK1
al Rabi, N; Artibani, W; Dalpiaz, O; Ficarra, V; Galfano, A; Martignoni, G1
Bor, MV; Nexø, E; Sørensen, BS; Tørring, N1
Cook, A; Izawa, JI; Mack, DP; Moussa, M1
deVere White, RW; Ellison, LM; Gandour-Edwards, R; Goldberg, Z; Karpman, E; Saffarian, A1
Bex, A; Horenblas, S; Kerst, M; Meinhardt, W; Nieuwenhuijzen, JA; Pos, F; van Boven, H1
Miyagawa, I; Sejima, T1
Adachi, S; Fukuhara, S; Hara, T; Mori, N; Tsutahara, K; Yamaguchi, S; Yokoyama, S1
Fujikawa, N; Hirai, K; Hirokawa, S; Kita, K; Kitami, K; Mikata, K; Sano, H; Ueki, T1
Kageyama, Y; Kihara, K; Kobayashi, T; Kubo, Y; Yokoyama, M1
Fujioka, H; Honda, M; Matsumiya, K; Satoh, M; Takada, T; Tujimoto, Y1
Bode, AM; Choi, BY; Choi, HS; Dong, Z; Ermakova, SP; Kang, BS; Ma, WY; Schuster, TF1
Kamoto, T; Kawahara, T; Nishiyama, H; Ogawa, O; Yamamoto, S1
Chang, CC; Lin, PR; Shiau, AL; Shieh, GS; Tzai, TS; Wu, CL; Yo, YT1
Memon, AA; Munk, M; Nexo, E; Sorensen, BS1
Kenna, T; Mattarollo, SR; Nicol, AJ; Nieda, M1
Cobo, ML; Gómez-Román, JJ; Val-Bernal, JF1
Uchibayashi, T1
Płuzańska, A; Robak, T1
Fujita, K; Murayama, T; Sayama, T1
Blatnik, A; Matheny, RB; Niell, HB; Soloway, MS1
Oliver, RT; Ponder, BA1
Seematter, RJ1
Kitamura, Y; Komatsubara, S; Sakata, Y; Watanabe, M2
Kawakami, M; Kobayashi, S; Niwakawa, M; Ogawa, A; Okaneya, T; Tsuruta, T1
Barzan, L; Canzonieri, V; Dal Bo, V; Lo Re, G; Trovò, M; Veronesi, A; Zancanaro, C1
Chuchkova, M; Damianov, C; Koleva, P; Terziev, T1
Hirano, A; Hiroi, A; Inagaki, T; Uekado, Y1
Kobayashi, H; Obata, K1
Chang, JH; Grossman, HB; Liebert, M; Shinohara, N; Wedemeyer, G1
Arakawa, S; Gotoh, A; Kamidono, S; Kitazawa, S; Maeda, S; Matsuwari, S; Mizuno, Y1
Hahn, RG; Hatcher, PA; Richardson, RL; Zincke, H1
Kondoh, M; Miki, T; Nakamura, N; Nakano, E; Nishimura, K; Okuyama, A; Seguchi, T1
Cassidy, J; Kaye, SB1
Igawa, M; Kadena, H; Matsuura, H; Ohkuchi, T; Ueda, M; Usui, T1
Inagaki, T; Touge, H; Uekado, Y; Watanabe, T1
Hasegawa, S; Koga, H; Kotoh, S; Kumazawa, J; Kuwano, M; Naito, S; Yokomizo, A1
Chresta, CM; Hickman, JA; Masters, JR1
Hashimoto, H; Iuchi, H; Morikawa, M; Numata, A; Tokumitsu, M; Yachiku, S; Yamauchi, K1
Aikawa, K; Irisawa, C; Ishibashi, K; Ishiwata, H; Koseki, K; Ogihara, M; Shiraiwa, Y1
Abu Rabia, A; el-Attar, I; el-Said, A; Gaafar, R; Gad el-Mawla, N; Hamza, MR; Khaled, HM; Magrath, I1
Akaza, H; Kawai, K1
Bleicher, RJ; Gupta, V; Singh, SV; Xia, H; Zaren, HA1
Aikawa, K; Ishibashi, K; Koseki, K; Ogihara, M; Shiraiwa, Y; Yamaguchi, O1
Clark, PI; Parr, NJ; Venkatesh, R1
Eishi, Y; Fukuda, H; Kanno, J; Kawakami, S; Kihara, K; Morita, T; Nagahama, K; Ohtsuka, Y; Okada, Y; Oshima, H; Saito, K1
Goessl, C; Heicappell, R; Miller, K; Müller, M; Steiner, U1
Chen, CL; Horng, YY; Kao, YL; Kuo, JH; Ou, YC; Yang, CR; Yang, CS; Yean, SY1
Horiuchi, S; Negishi, T; Tsukamoto, T; Urushibara, M1
Brehmer, B; Jakse, G; Kapp, T; Rohde, D; Valdor, M1
Hoshino, T; Iwamoto, T; Kuroko, K; Nishida, S; Shirai, C1
Arriola, EL; Chresta, CM; Lopez, AR1
Akaza, H; Tsukamoto, S1
Fujikawa, K; Hoshii, Y; Ishizu, K; Kawamura, H; Konishi, M; Naito, K; Ohmi, C; Shimizu, Y; Takahashi, M; Yamaguchi, S1
Arai, E; Horii, Y; Iwamura, H1
Deguchi, T; Kamei, S; Miwa, K; Nishida, Y; Takahashi, Y; Yamada, T1
Barret, JM; Etiévant, C; Guminski, Y; Hill, BT; Kruczynski, A; Perrin, D; van Hille, B1
Akinaga, S; Benedict, WF; Ko, K; Mizukami, T; Motoda, H; Shinohara, H; Takahashi, R; Tamaoki, T; Yamaoka, Y; Yazumi, S; Yoshida, T; Yoshikawa, K; Zhou, J1
Inoue, K; Kasahara, K; Shuin, T1
Fukui, I; Ishiwata, D; Kim, T; Tohma, T; Tsukamoto, T; Yonese, J; Yoshida, T1
Cowan, DS; Egorin, MJ; Lee, CM; Tannock, IF; Tunggal, JK1
Akaza, H; Hattori, K; Kawai, K; Miyanaga, N; Shimazui, T; Tsukamoto, S; Uchida, K1
Henney, JE; Muggia, FM; Rozencweig, M; Von Hoff, DD1
Hirano, A; Ohkawa, T; Shinka, T; Uekado, Y1
Ingargiola, GB; Pavone-Macaluso, M; Serretta, V1
Akiyama, M; Inoue, Y; Sumiyoshi, Y; Yokota, K1
Kondo, I; Miura, T; Murai, T; Shimura, H1
Eiro, I; Kanetsuki, I; Nakajo, M; Onohara, S; Takeshita, T; Uchiyama, N; Yano, T1
Chresta, CM; Davies, SM; Fry, AM; Harris, AL; Hartley, JA; Hickson, ID; Masters, JR; Walker, MC1
Colbeck, RA; Crawford, SM; Williams, G1
Floyd, JW; Lin, CW; Prout, GR1
Feng, MR; Grossman, HB; Liebert, M; Mancini, WR; Wagner, JG; Wedemeyer, G; Williams, M1
Akimoto, M; Hattori, T; Nishimura, T; Satoh, M; Terashima, Y1
Akiyama, M; Sumiyoshi, Y; Yokota, K1
Akao, T; Hashimura, T; Nakagawa, T; Okumura, K1
Morikawa, Y; Tanaka, S1
Miura, K; Tsukada, T; Yuri, Y1
Musk, SR; Steel, GG1
Kotake, T; Kuroda, M; Miki, T1
Davis, MP; Minton, JP; Murthy, MS; Simon, J; Wise, H1
Iizumi, T; Soma, G; Waku, M; Yazaki, T1
Itoh, K; Kokado, Y; Kyakuno, M; Sagawa, S; Sakai, H; Shin, T1
Buckley, NJ; Das, AK; Poulton, SH; Walther, PJ1
Alexander, RB; Coffey, DS; Isaacs, JT1
Suzuki, K1
Birch, R; Einhorn, LH; Greco, FA; Troner, M; Walther, PJ; Williams, SD1
Oliver, RT1
Aota, Y; Kinjo, T; Mitsuya, H; Murase, T; Shimoji, T1

Reviews

15 review(s) available for etoposide and Bladder Cancer

ArticleYear
[Intravesical Recurrence of Small Cell Carcinoma of the Ureter: A Case Report].
    Hinyokika kiyo. Acta urologica Japonica, 2016, Volume: 62, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Humans; Male; Middle Aged; Nephrectomy; Recurrence; Ureteral Neoplasms; Urinary Bladder Neoplasms

2016
[Plasmacytoid urothelial carcinoma of the bladder: a case report].
    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 2009, Volume: 100, Issue:5

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Diagnostic Imaging; Etoposide; Humans; Lymphatic Metastasis; Male; Methotrexate; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine

2009
[Case of primary hepatic neuroendocrine carcinoma diagnosed by needle biopsy].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2010, Volume: 107, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carcinoma, Neuroendocrine; Carcinoma, Transitional Cell; Cisplatin; Diagnosis, Differential; Diagnostic Imaging; Etoposide; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasms, Multiple Primary; Urinary Bladder Neoplasms

2010
[Small cell neuroendocrine carcinoma of the bladder: A case report and review of the literature].
    Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2011, Volume: 15, Issue:3

    Topics: Acute Kidney Injury; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Carcinoma in Situ; Carcinoma, Neuroendocrine; Carcinoma, Transitional Cell; Combined Modality Therapy; Emergencies; Etoposide; Humans; Lymphatic Irradiation; Lymphatic Metastasis; Male; Neoadjuvant Therapy; Neoplasms, Multiple Primary; Prognosis; Prostatic Hyperplasia; Topoisomerase I Inhibitors; Topotecan; Urinary Bladder Neoplasms

2011
Small cell carcinoma of the bladder: a case report and a literature review.
    Archivos espanoles de urologia, 2003, Volume: 56, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cystectomy; Doxorubicin; Etoposide; Fatal Outcome; Humans; Ifosfamide; Life Tables; Liver Neoplasms; Male; Middle Aged; Stevens-Johnson Syndrome; Survival Analysis; Urinary Bladder Neoplasms; Vincristine

2003
Analysis of treatment for small cell cancer of the bladder and report of three cases.
    Urology, 2004, Volume: 64, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Biomarkers, Tumor; Bone Neoplasms; Carboplatin; Carcinoma, Small Cell; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Cystectomy; Deoxycytidine; Disease Progression; Etoposide; Gemcitabine; Humans; Life Tables; Liver Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasms, Second Primary; Prostatectomy; Retrospective Studies; Treatment Outcome; Urinary Bladder Neoplasms; Urinary Diversion

2004
[The role of etoposide therapy in urogenital cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:14

    Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Female; Humans; Kidney Neoplasms; Male; Prostatic Neoplasms; Urinary Bladder Neoplasms; Vinblastine

1996
[Small cell carcinoma of the urinary bladder: a case report and review of the Japanese literature].
    Hinyokika kiyo. Acta urologica Japonica, 1997, Volume: 43, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Male; Middle Aged; Urinary Bladder Neoplasms

1997
[Progress in oral anti-cancer drug therapy for urological cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:3

    Topics: Administration, Oral; Androgen Antagonists; Antineoplastic Agents, Hormonal; Drug Administration Schedule; Drug Combinations; Estramustine; Etoposide; Female; Flutamide; Humans; Kidney Neoplasms; Male; Prostatic Neoplasms; Tegafur; Uracil; Urinary Bladder Neoplasms

1999
[Combined treatment with CDDP and radiation effective against neuroendocrine carcinoma of the urinary bladder: a case report].
    Hinyokika kiyo. Acta urologica Japonica, 1999, Volume: 45, Issue:7

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Male; Treatment Outcome; Urinary Bladder Neoplasms

1999
[Small cell neuroendocrine carcinoma of the urinary bladder: a case report].
    Hinyokika kiyo. Acta urologica Japonica, 1999, Volume: 45, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cystectomy; Etoposide; Humans; Lymphatic Metastasis; Male; Middle Aged; Urinary Bladder Neoplasms

1999
[Chemotherapy and radiotherapy for urological cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Kidney Neoplasms; Male; Methotrexate; Prostatic Neoplasms; Testicular Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Vinblastine

2002
VM 26 and VP 16-213: a comparative analysis.
    Cancer, 1977, Volume: 40, Issue:1

    Topics: Animals; Brain Neoplasms; Drug Evaluation; Etoposide; Humans; Kinetics; Leukemia; Lung Neoplasms; Lymphoma; Neoplasms, Experimental; Podophyllotoxin; Teniposide; Urinary Bladder Neoplasms

1977
The role of epipodophyllotoxin derivatives in bladder cancer.
    Seminars in oncology, 1992, Volume: 19, Issue:2 Suppl 6

    Topics: Combined Modality Therapy; Etoposide; Humans; Remission Induction; Teniposide; Urinary Bladder Neoplasms

1992
Small cell carcinoma of the urinary bladder: a case of remarkable remission with combined chemotherapy.
    Hinyokika kiyo. Acta urologica Japonica, 1988, Volume: 34, Issue:8

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Humans; Lymphatic Metastasis; Male; Remission Induction; Tomography, X-Ray Computed; Urinary Bladder Neoplasms

1988

Trials

9 trial(s) available for etoposide and Bladder Cancer

ArticleYear
Phase II clinical trial of neoadjuvant alternating doublet chemotherapy with ifosfamide/doxorubicin and etoposide/cisplatin in small-cell urothelial cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Jun-01, Volume: 27, Issue:16

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Prospective Studies; Time Factors; Treatment Outcome; Urinary Bladder Neoplasms; Urothelium

2009
[Bladder preservation for locally advanced bladder cancer by transurethral resection, systemic chemotherapy and radiation].
    Hinyokika kiyo. Acta urologica Japonica, 2006, Volume: 52, Issue:5

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cystectomy; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Radiotherapy Dosage; Urinary Bladder Neoplasms; Vinblastine

2006
[New antineoplastic drugs of the podophyllotoxin derivative group].
    Polski tygodnik lekarski (Warsaw, Poland : 1960), 1983, Jan-03, Volume: 38, Issue:1

    Topics: Adult; Child; Clinical Trials as Topic; Etoposide; Female; Humans; Leukemia; Lung Neoplasms; Lymphoma; Neoplasms; Ovarian Neoplasms; Podophyllotoxin; Teniposide; Urinary Bladder Neoplasms

1983
Combined immunochemotherapy (CEP, M-VEP + BCG) in the treatment of invasive bladder tumors.
    Anti-cancer drugs, 1994, Volume: 5, Issue:3

    Topics: Administration, Intravesical; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Cisplatin; Combined Modality Therapy; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Immunotherapy, Active; Lomustine; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Prednimustine; Urinary Bladder Neoplasms; Vinblastine

1994
[Intraarterial chemotherapy for patients with invasive bladder cancer--clinical effects and preliminary results in bladder preservation].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:13

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Neoplasm Invasiveness; Urinary Bladder; Urinary Bladder Neoplasms

1994
Results of adjuvant chemotherapy for invasive urothelial cancer with lymph-node metastasis.
    Cancer chemotherapy and pharmacology, 1994, Volume: 35 Suppl

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Kidney Neoplasms; Kidney Pelvis; Longitudinal Studies; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Survival Rate; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Vinblastine

1994
Neoadjuvant chemotherapy for invasive bladder carcinoma: disease outcome and bladder preservation and relationship to local tumor response.
    European urology, 1994, Volume: 25, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Survival Rate; Time Factors; Urinary Bladder Neoplasms; Vinblastine

1994
Combination chemotherapy for advanced bilharzial bladder carcinoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1996, Volume: 7, Issue:7

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Mesna; Middle Aged; Schistosomiasis; Survival Rate; Treatment Outcome; Urinary Bladder Neoplasms; Vincristine

1996
Results of adjuvant chemotherapy for invasive uroepithelial cancer.
    Cancer chemotherapy and pharmacology, 1992, Volume: 30 Suppl

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Kidney Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Survival Rate; Ureteral Neoplasms; Urinary Bladder Neoplasms

1992

Other Studies

87 other study(ies) available for etoposide and Bladder Cancer

ArticleYear
Studies on quinones. Part 47. Synthesis of novel phenylaminophenanthridinequinones as potential antitumor agents.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:8

    Topics: Aniline Compounds; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Fibroblasts; Humans; Inhibitory Concentration 50; Lung Neoplasms; Molecular Structure; Phenanthridines; Quinones; Stomach Neoplasms; Structure-Activity Relationship; Urinary Bladder Neoplasms

2011
Long-term complete response in small cell bladder carcinoma treated with carboplatin, etoposide, and atezolizumab.
    BMC urology, 2022, Nov-05, Volume: 22, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Humans; Lung Neoplasms; Male; Urinary Bladder; Urinary Bladder Neoplasms

2022
[A Case of Small Cell Carcinoma of the Bladder].
    Hinyokika kiyo. Acta urologica Japonica, 2020, Volume: 66, Issue:9

    Topics: Aged; Carcinoma, Small Cell; Cystectomy; Etoposide; Humans; Male; Urinary Bladder Neoplasms

2020
A Case of Ewing Sarcoma of the Bladder Presenting in Early Infancy.
    Journal of pediatric hematology/oncology, 2021, 05-01, Volume: 43, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hematuria; Humans; Ifosfamide; Infant; Sarcoma, Ewing; Treatment Outcome; Urinary Bladder; Urinary Bladder Neoplasms; Vincristine

2021
[A Case of Long Survival in Aggressively Growing Small Cell Carcinoma of the Bladder Successfully Treated by Combined Chemotherapy of Methotrexate, Etoposide and Cisplatin].
    Hinyokika kiyo. Acta urologica Japonica, 2017, Volume: 63, Issue:6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Humans; Magnetic Resonance Imaging; Male; Methotrexate; Time Factors; Urinary Bladder Neoplasms

2017
Durable response after VNCOP-B and rituximab in an elderly patient with high-grade B-cell lymphoma.
    Acta clinica Belgica, 2018, Volume: 73, Issue:6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Etoposide; Humans; Lymphoma, B-Cell; Male; Mitoxantrone; Prednisone; Rituximab; Urinary Bladder; Urinary Bladder Neoplasms; Vincristine

2018
Treatment of Small Cell Carcinoma of the Bladder With Chemotherapy and Radiation after Transurethral Resection of a Bladder Tumor.
    American journal of clinical oncology, 2016, Volume: 39, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Transitional Cell; Chemoradiotherapy, Adjuvant; Cisplatin; Cohort Studies; Cystoscopy; Disease-Free Survival; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Complex and Mixed; Organ Sparing Treatments; Retrospective Studies; Urinary Bladder; Urinary Bladder Neoplasms; Vinblastine; Vinorelbine

2016
A Case of Urachal Yolk Sac Tumor With Spontaneous Rupture in a Child.
    Journal of pediatric hematology/oncology, 2017, Volume: 39, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Carboplatin; Combined Modality Therapy; Consanguinity; Emergencies; Endodermal Sinus Tumor; Etoposide; Hemoperitoneum; Humans; Infant; Laparotomy; Male; Rupture, Spontaneous; Tomography, X-Ray Computed; Urachus; Urinary Bladder Neoplasms

2017
An Epigenomic Approach to Improving Response to Neoadjuvant Cisplatin Chemotherapy in Bladder Cancer.
    Biomolecules, 2016, 09-02, Volume: 6, Issue:3

    Topics: Antineoplastic Agents; Azacitidine; Biomarkers, Tumor; Cell Line, Tumor; Cisplatin; Decitabine; Doxorubicin; Drug Resistance, Neoplasm; Epigenomics; Etoposide; Homeodomain Proteins; Humans; Hydroxamic Acids; Methylation; Neoadjuvant Therapy; Promoter Regions, Genetic; Urinary Bladder Neoplasms; Vinblastine; Vorinostat

2016
Long term disease free survival with multimodal therapy in small cell bladder cancer.
    European journal of medical research, 2016, Oct-13, Volume: 21, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cystectomy; Disease-Free Survival; Etoposide; Humans; Lymph Node Excision; Male; Middle Aged; Prostatectomy; Treatment Outcome; Urinary Bladder Neoplasms

2016
Combination chemotherapy of ifosfamide, 5-fluorouracil, etoposide and cisplatin as perioperative treatment in lymph node positive bladder carcinoma patients treated by radical cystectomy.
    International journal of urology : official journal of the Japanese Urological Association, 2008, Volume: 15, Issue:11

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cystectomy; Etoposide; Female; Fluorouracil; Humans; Ifosfamide; Lymphatic Metastasis; Male; Middle Aged; Survival Rate; Urinary Bladder Neoplasms

2008
A rare case of simultaneous occurrence of Wilms' tumor in the left kidney and the bladder.
    Pediatric surgery international, 2010, Volume: 26, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Humans; Infant; Kidney Neoplasms; Male; Neoplasms, Multiple Primary; Ultrasonography; Urinary Bladder Neoplasms; Vincristine; Wilms Tumor

2010
Impact of C-reactive protein kinetics on survival of patients with advanced urothelial carcinoma treated by second-line chemotherapy with gemcitabine, etoposide and cisplatin.
    BJU international, 2012, Volume: 110, Issue:10

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; C-Reactive Protein; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Etoposide; Female; Gemcitabine; Humans; Male; Middle Aged; Prognosis; Survival Rate; Urinary Bladder Neoplasms

2012
Large cell neuroendocrine carcinoma (LCNEC) of the urinary bladder: a case report.
    Diagnostic pathology, 2013, Feb-04, Volume: 8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Etoposide; Fatal Outcome; Female; Humans; Immunohistochemistry; Middle Aged; Neoadjuvant Therapy; Treatment Outcome; Urinary Bladder Neoplasms

2013
Primary yolk sac tumor of the urachus.
    Archives of pathology & laboratory medicine, 2002, Volume: 126, Issue:9

    Topics: alpha 1-Antitrypsin; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; DNA, Neoplasm; Endodermal Sinus Tumor; Etoposide; Flow Cytometry; Humans; Immunohistochemistry; Infant; Keratins; Male; Nuclear Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; Tomography, X-Ray Computed; Treatment Outcome; Urachus; Urinary Bladder Neoplasms

2002
[Combination chemotherapy with ifosfamide, 5-fuluorouracil, etoposide and cisplatin for advanced urothelial cancer: the treatment results and significance of tumor marker evaluation in response assessment of chemotherapy].
    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 2002, Volume: 93, Issue:7

    Topics: Aged; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; CA-19-9 Antigen; Carcinoembryonic Antigen; Carcinoma, Transitional Cell; Cisplatin; Etoposide; Evaluation Studies as Topic; Female; Fluorouracil; Humans; Ifosfamide; Male; Middle Aged; Serpins; Urinary Bladder Neoplasms; Urologic Neoplasms

2002
The effects of chemotherapeutic agents on the regulation of thrombin on cell surfaces.
    British journal of haematology, 2003, Volume: 120, Issue:2

    Topics: alpha-Macroglobulins; Antineoplastic Agents; Antithrombins; Cell Membrane; Doxorubicin; Etoposide; Humans; Methotrexate; Prothrombin; Thrombin; Thromboplastin; Thrombosis; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Vincristine

2003
Endoplasmic reticulum chaperone protein GRP78 protects cells from apoptosis induced by topoisomerase inhibitors: role of ATP binding site in suppression of caspase-7 activation.
    The Journal of biological chemistry, 2003, Jun-06, Volume: 278, Issue:23

    Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Binding Sites; Camptothecin; Carrier Proteins; Caspase 7; Caspases; Cell Membrane; Cricetinae; Doxorubicin; Endoplasmic Reticulum; Endoplasmic Reticulum Chaperone BiP; Enzyme Precursors; Etoposide; G1 Phase; Gene Expression; Heat-Shock Proteins; Humans; Leukemia; Molecular Chaperones; Protein Structure, Tertiary; Subcellular Fractions; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Transfection; Tumor Cells, Cultured; Urinary Bladder Neoplasms

2003
The DNA damaging agent VP16 induces the expression of a subset of ligands from the EGF system in bladder cancer cells, whereas none of the four EGF receptors are induced.
    Molecular and cellular biochemistry, 2004, Volume: 260, Issue:1-2

    Topics: Amphiregulin; Antineoplastic Agents, Phytogenic; Betacellulin; Cell Line, Tumor; Cell Membrane; Cycloheximide; Dose-Response Relationship, Drug; EGF Family of Proteins; Epidermal Growth Factor; Epiregulin; ErbB Receptors; Etoposide; Gene Expression Regulation, Neoplastic; Glycoproteins; Humans; Intercellular Signaling Peptides and Proteins; Ligands; Protein Synthesis Inhibitors; RNA, Messenger; Transforming Growth Factor alpha; Urinary Bladder Neoplasms

2004
Metastatic Merkel cell tumor to the prostate and bladder.
    Urology, 2004, Volume: 64, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Merkel Cell; Combined Modality Therapy; Etoposide; Facial Neoplasms; Fatal Outcome; Humans; Kidney Neoplasms; Liver Neoplasms; Lymphatic Metastasis; Male; Palliative Care; Prostatic Neoplasms; Radiotherapy, Adjuvant; Spinal Neoplasms; Transurethral Resection of Prostate; Urethral Obstruction; Urinary Bladder Neoplasms

2004
Small cell carcinoma of bladder: a single-center prospective study of 25 cases treated in analogy to small cell lung cancer.
    Urology, 2005, Volume: 65, Issue:2

    Topics: Age Factors; Aged; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Comorbidity; Cyclophosphamide; Cystectomy; Doxorubicin; Etoposide; Feasibility Studies; Female; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Palliative Care; Prognosis; Prospective Studies; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine

2005
'Successful' chemo- and radiotherapy prior to radical cystectomy does not necessarily correlate with clinical course in small cell carcinoma of the bladder.
    Urologia internationalis, 2005, Volume: 74, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cystectomy; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Male; Preoperative Care; Treatment Outcome; Urinary Bladder Neoplasms

2005
[Small cell carcinoma of the urinary bladder: a case report].
    Hinyokika kiyo. Acta urologica Japonica, 2005, Volume: 51, Issue:6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Urinary Bladder Neoplasms

2005
[Small cell carcinoma of the bladder: a case report].
    Hinyokika kiyo. Acta urologica Japonica, 2005, Volume: 51, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Carcinoma, Transitional Cell; Combined Modality Therapy; Cystectomy; Drug Administration Schedule; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms, Multiple Primary; Urinary Bladder Neoplasms; Urinary Diversion

2005
[A case of secondary malignant lymphoma of the urinary bladder].
    Hinyokika kiyo. Acta urologica Japonica, 2006, Volume: 52, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Mesna; Middle Aged; Mitoxantrone; Prednisone; Urinary Bladder Neoplasms; Vincristine

2006
(-)-Epigallocatechin gallate overcomes resistance to etoposide-induced cell death by targeting the molecular chaperone glucose-regulated protein 78.
    Cancer research, 2006, Sep-15, Volume: 66, Issue:18

    Topics: Adenosine Triphosphatases; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Caspase 7; Caspase Inhibitors; Catechin; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Endoplasmic Reticulum Chaperone BiP; Etoposide; Heat-Shock Proteins; Humans; Mice; Molecular Chaperones; Protein Conformation; Urinary Bladder Neoplasms

2006
Protocol consisting of cisplatin, etoposide and irinotecan induced complete pathological remission of primary small cell carcinoma of the bladder.
    International journal of urology : official journal of the Japanese Urological Association, 2006, Volume: 13, Issue:9

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Etoposide; Humans; Irinotecan; Male; Neoadjuvant Therapy; Remission Induction; Urinary Bladder Neoplasms

2006
Low-dose etoposide enhances telomerase-dependent adenovirus-mediated cytosine deaminase gene therapy through augmentation of adenoviral infection and transgene expression in a syngeneic bladder tumor model.
    Cancer research, 2006, Oct-15, Volume: 66, Issue:20

    Topics: Adenoviridae; Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Combined Modality Therapy; Coxsackie and Adenovirus Receptor-Like Membrane Protein; Cytosine Deaminase; Dose-Response Relationship, Drug; Drug Synergism; Etoposide; Flucytosine; Genetic Therapy; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Mice, Inbred C3H; Promoter Regions, Genetic; Receptors, Virus; Telomerase; Transgenes; Up-Regulation; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays

2006
Inhibition of the epidermal growth factor receptor in bladder cancer cells treated with the DNA-damaging drug etoposide markedly increases apoptosis.
    BJU international, 2007, Volume: 99, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Survival; ErbB Receptors; Etoposide; Gefitinib; Humans; Quinazolines; Treatment Outcome; Urinary Bladder Neoplasms

2007
Chemotherapy and zoledronate sensitize solid tumour cells to Vgamma9Vdelta2 T cell cytotoxicity.
    Cancer immunology, immunotherapy : CII, 2007, Volume: 56, Issue:8

    Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Burkitt Lymphoma; Carcinoma; Cell Line, Tumor; Cisplatin; Colorectal Neoplasms; Concanavalin A; Cytotoxicity, Immunologic; Diphosphonates; Doxorubicin; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; Female; Genes, T-Cell Receptor delta; Genes, T-Cell Receptor gamma; Humans; Imidazoles; Interferon-gamma; Lovastatin; Lung Neoplasms; Male; Membrane Glycoproteins; Neoplasms; Perforin; Pore Forming Cytotoxic Proteins; Prostatic Neoplasms; Receptors, Antigen, T-Cell, gamma-delta; T-Lymphocyte Subsets; Urinary Bladder Neoplasms; Vincristine; Zoledronic Acid

2007
Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma presenting as a bladder neoplasm.
    Pathology international, 2008, Volume: 58, Issue:4

    Topics: Anaplastic Lymphoma Kinase; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Transitional Cell; Cisplatin; Cytarabine; Diagnosis, Differential; Disease-Free Survival; Etoposide; Humans; Ki-1 Antigen; Lymphoma, Large-Cell, Anaplastic; Male; Methylprednisolone; Middle Aged; Mucin-1; Protein-Tyrosine Kinases; Receptor Protein-Tyrosine Kinases; Treatment Outcome; Urinary Bladder Neoplasms

2008
[Chemosensitivity in established human bladder carcinoma and HELA cell lines in vitro].
    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 1983, Volume: 74, Issue:9

    Topics: Antineoplastic Agents; Bleomycin; Carbazilquinone; Carcinoma, Transitional Cell; Cell Division; Cell Line; Cell Survival; Cells, Cultured; Cisplatin; Doxorubicin; Drug Evaluation, Preclinical; Etoposide; HeLa Cells; Humans; Male; Mitomycin; Mitomycins; Nimustine; Nitrosourea Compounds; Thiotepa; Urinary Bladder Neoplasms

1983
[Effect of etoposide for pulmonary metastases from urogenital tract cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1984, Volume: 11, Issue:11

    Topics: Adenocarcinoma; Administration, Oral; Aged; Carcinoma, Transitional Cell; Etoposide; Humans; Infusions, Parenteral; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Prostatic Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms

1984
Systemic chemotherapy of murine bladder cancer.
    Urology, 1984, Volume: 23, Issue:4 Suppl

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cell Line; Cisplatin; Disease Models, Animal; Dose-Response Relationship, Drug; Etoposide; FANFT; Female; Methotrexate; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Urinary Bladder Neoplasms

1984
Phase II study of VP 16-213 (etoposide) in metastatic transitional cell urothelial cancer.
    Cancer chemotherapy and pharmacology, 1984, Volume: 12, Issue:1

    Topics: Adult; Aged; Carcinoma, Transitional Cell; Drug Evaluation; Etoposide; Humans; Infusions, Parenteral; Middle Aged; Podophyllotoxin; Urinary Bladder Neoplasms

1984
[Systemic chemotherapy of bladder cancer].
    Helvetica chirurgica acta, 1982, Volume: 49, Issue:3-4

    Topics: Aged; Antineoplastic Agents; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Humans; Middle Aged; Urinary Bladder Neoplasms

1982
[Comparative study on urinary parameters reflecting renal damage during chemotherapy for urological cancer].
    Hinyokika kiyo. Acta urologica Japonica, 1993, Volume: 39, Issue:2

    Topics: Acetylglucosaminidase; Adolescent; Adult; Aged; Aminopeptidases; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD13 Antigens; Cisplatin; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Etoposide; Humans; Ifosfamide; Kidney Diseases; Male; Methotrexate; Middle Aged; Prostatic Neoplasms; Proteinuria; Urinary Bladder Neoplasms; Vincristine

1993
[Optimal way of administration of granulocyte colony stimulating factor in the treatment of urological cancer].
    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 1993, Volume: 84, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Male; Methotrexate; Middle Aged; Testicular Neoplasms; Ureteral Neoplasms; Urinary Bladder Neoplasms; Vinblastine

1993
Extrapulmonary small cell carcinoma: a single-institution experience and review of the literature.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Laryngeal Neoplasms; Male; Middle Aged; Prostatic Neoplasms; Remission Induction; Retrospective Studies; Urinary Bladder Neoplasms

1994
Evaluation of multiple drug resistance in human bladder cancer cell lines.
    The Journal of urology, 1993, Volume: 150, Issue:2 Pt 1

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Carrier Proteins; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Etoposide; Humans; Membrane Glycoproteins; Neoplasm Proteins; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Verapamil

1993
[Evaluation of the anticancer effect of cisplatin and etoposide against nude mice transplanted urological malignant tumors].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:6

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Drug Evaluation; Etoposide; Humans; Infusions, Parenteral; Kidney Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Urinary Bladder Neoplasms

1994
[MEP (methotrexate, etoposide and cisplatin) and M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced uroepithelial cancer--a preliminary report of MEP as second line chemotherapy for recurrence after M-VAC].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Ureteral Neoplasms; Urinary Bladder Neoplasms; Vinblastine

1994
An unusual case of haematuria.
    European journal of cancer (Oxford, England : 1990), 1993, Volume: 29A, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Hematuria; Humans; Ifosfamide; Male; Mesna; Quadriplegia; Urinary Bladder Neoplasms

1993
Myocardial ischemia after treatment with methotrexate, etoposide and cisplatin.
    Urologia internationalis, 1993, Volume: 50, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Humans; Male; Methotrexate; Middle Aged; Myocardial Ischemia; Urinary Bladder Neoplasms

1993
[A case of complete response was achieved with arterial infusion chemotherapy including CDDP, etoposide and pirarubicin].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:8

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Etoposide; Humans; Infusions, Intra-Arterial; Male; Preoperative Care; Remission Induction; Urinary Bladder; Urinary Bladder Neoplasms

1993
Non-P-glycoprotein-mediated atypical multidrug resistance in a human bladder cancer cell line.
    Japanese journal of cancer research : Gann, 1995, Volume: 86, Issue:11

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Carcinoma, Transitional Cell; Cisplatin; DNA Topoisomerases, Type II; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Fluorouracil; Humans; Mitomycin; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Selection, Genetic; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Verapamil; Vinca Alkaloids

1995
Hypersensitivity of human testicular tumors to etoposide-induced apoptosis is associated with functional p53 and a high Bax:Bcl-2 ratio.
    Cancer research, 1996, Apr-15, Volume: 56, Issue:8

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Cell Line; Cell Survival; DNA Damage; DNA, Neoplasm; Dose-Response Relationship, Drug; Etoposide; Flow Cytometry; Humans; Male; Nocodazole; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Testicular Neoplasms; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Urinary Bladder Neoplasms

1996
[Chemotherapy for advanced urothelial cancer patients with a combination of low-dose consecutive cisplatin and etoposide].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:7

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Kidney Neoplasms; Male; Middle Aged; Urinary Bladder Neoplasms

1996
[Efficacy of the chemosensitivity test using collagen gel matrix-supported culture system for urogenital tumors].
    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 1996, Volume: 87, Issue:4

    Topics: Animals; Antineoplastic Agents; Bleomycin; Carcinoma, Renal Cell; Cisplatin; Collagen; Culture Media; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Female; Humans; Kidney Neoplasms; Mice; Mice, Inbred C3H; Mitomycin; Urinary Bladder Neoplasms; Vinblastine

1996
Mechanism of increased sensitivity to etoposide in a mitomycin C-resistant human bladder cancer cell line.
    International journal of cancer, 1997, Mar-04, Volume: 70, Issue:5

    Topics: Antineoplastic Agents, Phytogenic; DNA Topoisomerases, Type II; Drug Resistance, Neoplasm; Etoposide; Humans; Mitomycin; Tumor Cells, Cultured; Tumor Stem Cell Assay; Urinary Bladder Neoplasms

1997
[Neoadjuvant intra-arterial chemotherapy based on chemosensitivity tests for locally invasive bladder cancer].
    Hinyokika kiyo. Acta urologica Japonica, 1997, Volume: 43, Issue:8

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Drug Administration Schedule; Drug Screening Assays, Antitumor; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Mitomycin; Peplomycin; Prognosis; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Vinblastine

1997
Extragonadal germ cell tumour involving the urinary bladder.
    British journal of urology, 1997, Volume: 80, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Male; Middle Aged; Teratoma; Urinary Bladder Neoplasms

1997
Side effects of chemotherapy for advanced urothelial carcinoma with etoposide and ifosfamide.
    Urologia internationalis, 1997, Volume: 59, Issue:4

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Etoposide; Female; Humans; Ifosfamide; Kidney Neoplasms; Male; Middle Aged; Urinary Bladder Neoplasms

1997
Intracellular glutathione content of urothelial cancer in correlation to chemotherapy response.
    Cancer letters, 1997, Nov-11, Volume: 119, Issue:2

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cytarabine; Drug Resistance, Neoplasm; Etoposide; Female; Glutathione; Humans; Male; Middle Aged; Mitoxantrone; Ureteral Neoplasms; Urinary Bladder Neoplasms

1997
[Usefulness of magnetic resonance imaging for evaluation of therapeutic efficacy of bone metastases from bladder cancer: a case report].
    Hinyokika kiyo. Acta urologica Japonica, 1998, Volume: 44, Issue:7

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Magnetic Resonance Imaging; Male; Methotrexate; Urinary Bladder Neoplasms; Vinblastine

1998
Induction of drug-resistant bladder carcinoma cells in vitro: impact on polychemotherapy with cisplatin, methotrexate and vinblastine (CMV).
    Urological research, 1998, Volume: 26, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cell Cycle; Cell Division; Cisplatin; DNA, Neoplasm; Drug Resistance, Neoplasm; Etoposide; Flow Cytometry; Humans; Methotrexate; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Vinblastine

1998
[A case of primary malignant lymphoma of the bladder].
    Hinyokika kiyo. Acta urologica Japonica, 1998, Volume: 44, Issue:8

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisolone; Remission Induction; Urinary Bladder Neoplasms; Vincristine

1998
Differential regulation of p21waf-1/cip-1 and Mdm2 by etoposide: etoposide inhibits the p53-Mdm2 autoregulatory feedback loop.
    Oncogene, 1999, Jan-28, Volume: 18, Issue:4

    Topics: Antineoplastic Agents; Apoptosis; Bleomycin; Carcinoma, Transitional Cell; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA Damage; DNA Repair; DNA, Neoplasm; Etoposide; Feedback; Humans; Male; Nuclear Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; Testicular Neoplasms; Testis; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Urinary Bladder Neoplasms

1999
[Small cell carcinoma of the urinary bladder: a case report].
    Hinyokika kiyo. Acta urologica Japonica, 2000, Volume: 46, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Drug Administration Schedule; Etoposide; Humans; Male; Middle Aged; Neoplasm Staging; Treatment Outcome; Urinary Bladder Neoplasms

2000
F 11782, a dual inhibitor of topoisomerases I and II with an original mechanism of action in vitro, and markedly superior in vivo antitumour activity, relative to three other dual topoisomerase inhibitors, intoplicin, aclarubicin and TAS-103.
    Cancer chemotherapy and pharmacology, 2000, Volume: 46, Issue:2

    Topics: Aclarubicin; Aminoquinolines; Animals; Antineoplastic Agents; Cell Division; Enzyme Inhibitors; Etoposide; Humans; Indenes; Indoles; Leukemia L1210; Leukemia P388; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Naphthalenes; Pyrans; Pyridines; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Urinary Bladder Neoplasms

2000
Retinoblastoma protein-initiated cellular growth arrest overcomes the ability of cotransfected wild-type p53 to induce apoptosis.
    British journal of cancer, 2000, Volume: 83, Issue:8

    Topics: Animals; Apoptosis; Cell Cycle; Cyclin-Dependent Kinase Inhibitor p16; Etoposide; Genes, p53; Genes, Retinoblastoma; Humans; Mice; Mice, Nude; Recombinant Proteins; Retinoblastoma Protein; Reverse Transcriptase Polymerase Chain Reaction; Transfection; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays

2000
Advanced adenocarcinoma of the urinary bladder successfully treated by the combination of cisplatinum, mitomycin-C, etoposide and tegafur-uracil chemotherapy.
    International journal of urology : official journal of the Japanese Urological Association, 2001, Volume: 8, Issue:3

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Humans; Middle Aged; Mitomycin; Neoplasm Staging; Remission Induction; Tegafur; Urinary Bladder Neoplasms

2001
Combination chemotherapy with ifosfamide, 5-fluorouracil, etoposide and cisplatin for metastatic urothelial cancer.
    Cancer chemotherapy and pharmacology, 2001, Volume: 48, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cisplatin; Etoposide; Female; Fluorouracil; Humans; Ifosfamide; Male; Middle Aged; Urinary Bladder Neoplasms

2001
Limited penetration of anticancer drugs through tumor tissue: a potential cause of resistance of solid tumors to chemotherapy.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2002, Volume: 8, Issue:3

    Topics: Animals; Antineoplastic Agents; Biological Availability; Cisplatin; Deoxycytidine; Diffusion; Drug Resistance, Neoplasm; Etoposide; Gemcitabine; Humans; Mammary Neoplasms, Experimental; Membranes, Artificial; Mice; Neoplasm Staging; Paclitaxel; Polytetrafluoroethylene; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Vinblastine

2002
[Intra-arterial infusion chemotherapy of advanced bladder cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:10 Suppl

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cisplatin; Drug Administration Schedule; Epirubicin; Etoposide; Female; Humans; Infusions, Intra-Arterial; Male; Prognosis; Urinary Bladder Neoplasms

1992
[MEC treatment (methotrexate, etoposide, cisplatin) for urothelial cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Kidney Neoplasms; Male; Methotrexate; Middle Aged; Urinary Bladder Neoplasms

1992
[Combined treatment of invasive bladder cancer by intra-arterial infusion chemotherapy of cisplatin with or without other anticancer agents and concurrent radiotherapy--initial response and side effects].
    Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica, 1992, Jun-25, Volume: 52, Issue:6

    Topics: Aged; Aged, 80 and over; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Humans; Iliac Artery; Infusions, Intravenous; Japan; Male; Methotrexate; Middle Aged; Retrospective Studies; Urinary Bladder Neoplasms

1992
Relationship between topoisomerase II level and chemosensitivity in human tumor cell lines.
    Cancer research, 1991, Dec-15, Volume: 51, Issue:24

    Topics: Amsacrine; Blotting, Western; Cell Death; Cross-Linking Reagents; DNA Damage; DNA Topoisomerases, Type II; Doxorubicin; Etoposide; Humans; In Vitro Techniques; Male; Testicular Neoplasms; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Urinary Bladder Neoplasms

1991
Treatment of bladder carcinoma using a germ cell chemotherapy protocol.
    British journal of urology, 1990, Volume: 65, Issue:5

    Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Carcinoembryonic Antigen; Carcinoma, Transitional Cell; Chorionic Gonadotropin; Cisplatin; Etoposide; Humans; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Urinary Bladder Neoplasms; Vincristine

1990
Multi-drug resistance of a doxorubicin-resistant bladder cancer cell line.
    The Journal of urology, 1990, Volume: 144, Issue:1

    Topics: Bleomycin; Cell Survival; Doxorubicin; Drug Resistance; Etoposide; Humans; Tumor Cells, Cultured; Tumor Stem Cell Assay; Urinary Bladder Neoplasms; Vinblastine

1990
Effect of verapamil on the uptake and efflux of etoposide (VP16) in both sensitive and resistant cancer cells.
    Selective cancer therapeutics, 1991,Summer, Volume: 7, Issue:2

    Topics: Animals; Carcinoma, Transitional Cell; Culture Media; Drug Resistance; Etoposide; Glucose; Humans; Kinetics; Leukemia L1210; Mice; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Verapamil

1991
[The activity of etoposide (VP16) in combination chemotherapy against human bladder cancer cells in vitro].
    Hinyokika kiyo. Acta urologica Japonica, 1991, Volume: 37, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Etoposide; Humans; Methotrexate; Tumor Cells, Cultured; Tumor Stem Cell Assay; Urinary Bladder Neoplasms; Vinblastine

1991
[Intra-arterial infusion chemotherapy for advanced bladder cancer and prostate cancer using reservoir system].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1991, Volume: 18, Issue:11

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Epirubicin; Etoposide; Female; Humans; Infusion Pumps; Infusions, Intra-Arterial; Male; Middle Aged; Prognosis; Prostatic Neoplasms; Urinary Bladder Neoplasms

1991
[Combination chemotherapy of methotrexate, etoposide, adriamycin and cisplatin (M-EAP) for advanced urothelial cancer].
    Hinyokika kiyo. Acta urologica Japonica, 1991, Volume: 37, Issue:7

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Male; Methotrexate; Middle Aged; Prognosis; Ureteral Neoplasms; Urinary Bladder Neoplasms

1991
[Complete remission of bone metastasis of bladder cancer treated by cisplatin-etoposide therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1991, Volume: 18, Issue:6

    Topics: Acetabulum; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Combined Modality Therapy; Cystectomy; Drug Administration Schedule; Etoposide; Humans; Male; Remission Induction; Urinary Bladder Neoplasms

1991
[Effect of etoposide orally administered every other day for the prevention of recurrence of bladder tumor].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:7

    Topics: Administration, Intravesical; Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Postoperative Period; Urinary Bladder Neoplasms

1990
The inhibition of cellular recovery in human tumour cells by inhibitors of topoisomerase.
    British journal of cancer, 1990, Volume: 62, Issue:3

    Topics: Camptothecin; Cell Survival; DNA; DNA Repair; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Drug Combinations; Etoposide; Humans; Radiation Tolerance; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Urinary Bladder Neoplasms

1990
[Plasma methotrexate concentrations in urothelial cancer chemotherapy].
    Hinyokika kiyo. Acta urologica Japonica, 1990, Volume: 36, Issue:9

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Kidney Neoplasms; Kidney Pelvis; Male; Methotrexate; Middle Aged; Urinary Bladder Neoplasms

1990
[Clinical evaluation of chemotherapy in urologic cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:4 Pt 2-2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Staging; Penile Neoplasms; Prognosis; Remission Induction; Testicular Neoplasms; Urinary Bladder Neoplasms; Urogenital Neoplasms; Vinblastine

1989
Successful management of small cell carcinoma of the bladder with cisplatin and etoposide.
    The Journal of urology, 1989, Volume: 142, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Humans; Male; Middle Aged; Urinary Bladder Neoplasms

1989
Immunochemotherapy for murine bladder tumor with a new human recombinant tumor necrosis factor (rTNF-S), VP-16 and hyperthermia.
    The Journal of urology, 1989, Volume: 142, Issue:2 Pt 1

    Topics: Animals; Carcinoma, Transitional Cell; Combined Modality Therapy; Etoposide; Female; Humans; Hyperthermia, Induced; Immunotherapy; Mice; Mice, Inbred C3H; Recombinant Proteins; Species Specificity; Tumor Necrosis Factor-alpha; Urinary Bladder Neoplasms

1989
Recombinant human tumor necrosis factor alone and with chemotherapeutic agents. Effect on nude mouse-supported human bladder cancer heterografts.
    Archives of surgery (Chicago, Ill. : 1960), 1989, Volume: 124, Issue:1

    Topics: Animals; Antineoplastic Agents; Carcinoma, Transitional Cell; Cell Line; Cisplatin; Dactinomycin; Doxorubicin; Drug Synergism; Drug Therapy, Combination; Etoposide; Mice; Mice, Nude; Neoplasm Transplantation; Recombinant Proteins; Subrenal Capsule Assay; Tumor Necrosis Factor-alpha; Urinary Bladder Neoplasms

1989
Tumor necrosis factor enhances the in vitro and in vivo efficacy of chemotherapeutic drugs targeted at DNA topoisomerase II in the treatment of murine bladder cancer.
    The Journal of urology, 1987, Volume: 138, Issue:2

    Topics: Animals; Antineoplastic Agents; Dactinomycin; DNA Topoisomerases, Type II; Doxorubicin; Etoposide; Female; Glycoproteins; Macrophage Activation; Mice; Recombinant Proteins; Teniposide; Tumor Necrosis Factor-alpha; Urinary Bladder Neoplasms

1987
[Phase II study of etoposide (VP-16-213) in genitourinary tumors. VP-16-213 Genitourinary Study Group].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1986, Volume: 13, Issue:9

    Topics: Adult; Aged; Alopecia; Anorexia; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Male; Middle Aged; Nausea; Podophyllotoxin; Prostatic Neoplasms; Testicular Neoplasms; Urinary Bladder Neoplasms; Urogenital Neoplasms

1986
Phase II study of etoposide for carcinoma of the bladder: the Southeastern Cancer Study Group experience.
    Cancer treatment reports, 1986, Volume: 70, Issue:11

    Topics: Drug Evaluation; Etoposide; Humans; Urinary Bladder Neoplasms

1986
Chemotherapy of invasive carcinoma of the bladder.
    The Australian and New Zealand journal of surgery, 1985, Volume: 55, Issue:3

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Etoposide; Humans; Lymphatic Metastasis; Methotrexate; Neoplasm Invasiveness; Urinary Bladder Neoplasms

1985
[Effect of etoposide for urogenital tumors].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1985, Volume: 12, Issue:6

    Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Aged; Antineoplastic Agents, Phytogenic; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Pancreatic Neoplasms; Podophyllotoxin; Prostatic Neoplasms; Rhabdomyosarcoma; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urogenital Neoplasms

1985